1 Product identity
Ingredient risk
Not yet assessed
BLDB Tonic
BrandSystemic Formulas Bio Challenge→Other Combinations Capsule 12 ingredients DSLD #22133Net contents: 60 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-06-25
2 Ingredients (12)
IngredientGroupSafety
Proprietary BlendProprietary Blend (Combination)—
RNA/DNA Hemoglobin Tissue FactorsBlend (Combination)—
YuccaYucca—
BurdockBurdock —
RNA/DNA Liver Tissue FactorsBlend (Combination)—
RNA/DNA Kidney Tissue FactorsBlend (Combination)—
RNA/DNA Spleen Tissue FactorsBlend (Combination)—
Alpha-Glucan OligosaccharideAlpha Glucans—
GelatinGelatin—
Stearic AcidStearic Acid—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
L-Leucine — Limited Evidence
⚠ May worsen pellagra
⚠ High doses may impair glucose metabolism
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID22133
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-06-25
6 More from Systemic Formulas Bio Challenge
APHA pH ControlARTA JointezATAK Immune RejuvenatorBIND Toxin EliminationCLNZ ChelatorDIJS Acideze7 Cite this page
Vancouver
Pkhakadze G. BLDB Tonic — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 28]. Available from: https://supplement.ge/products/bldb-tonic-22133/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG